BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17364850)

  • 1. Changes in the use of medical services and prescription drugs among heroin users over two years.
    Darke S; Havard A; Ross J; Williamson A; Mills KL; Teesson M
    Drug Alcohol Rev; 2007 Mar; 26(2):153-9. PubMed ID: 17364850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reductions in heroin use are not associated with increases in other drug use: 2-year findings from the Australian Treatment Outcome Study.
    Darke S; Williamson A; Ross J; Teesson M
    Drug Alcohol Depend; 2006 Sep; 84(2):201-5. PubMed ID: 16580792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of treatment on 3 years' outcome for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Teesson M; Mills K; Ross J; Darke S; Williamson A; Havard A
    Addiction; 2008 Jan; 103(1):80-8. PubMed ID: 17995994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between cocaine use and short-term outcomes for the treatment of heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Williamson A; Darke S; Ross J; Teesson M
    Drug Alcohol Rev; 2006 Mar; 25(2):141-8. PubMed ID: 16627303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of major depression and drug-related problems amongst heroin users across 36 months.
    Darke S; Mills K; Teesson M; Ross J; Williamson A; Havard A
    Psychiatry Res; 2009 Mar; 166(1):7-14. PubMed ID: 19215987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of sustained heroin abstinence amongst long-term, dependent heroin users: 36 months findings from the Australian Treatment Outcome Study (ATOS).
    Darke S; Ross J; Mills KL; Williamson A; Havard A; Teesson M
    Addict Behav; 2007 Sep; 32(9):1897-906. PubMed ID: 17289282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Teesson M; Ross J; Darke S; Lynskey M; Ali R; Ritter A; Cooke R
    Drug Alcohol Depend; 2006 Jun; 83(2):174-80. PubMed ID: 16343809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes after detoxification for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Teesson M; Havard A; Ross J; Darke S
    Drug Alcohol Rev; 2006 May; 25(3):241-7. PubMed ID: 16753648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health service utilization and benzodiazepine use among heroin users: findings from the Australian Treatment Outcome Study (ATOS).
    Darke S; Ross J; Teesson M; Lynskey M
    Addiction; 2003 Aug; 98(8):1129-35. PubMed ID: 12873247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attempted suicide among heroin users: 12-month outcomes from the Australian Treatment Outcome Study (ATOS).
    Darke S; Williamson A; Ross J; Teesson M
    Drug Alcohol Depend; 2005 May; 78(2):177-86. PubMed ID: 15845321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a sustained heroin shortage in three Australian States.
    Degenhardt L; Day C; Dietze P; Pointer S; Conroy E; Collins L; Hall W
    Addiction; 2005 Jul; 100(7):908-20. PubMed ID: 15954999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes and predictors of change in the physical health status of heroin users over 24 months.
    Williamson A; Darke S; Ross J; Teesson M
    Addiction; 2009 Mar; 104(3):465-70. PubMed ID: 19207357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Topping up' methadone: an analysis of patterns of heroin use among a treatment sample of Scottish drug users.
    Bloor M; McIntosh J; McKeganey N; Robertson M
    Public Health; 2008 Oct; 122(10):1013-9. PubMed ID: 18490036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of prescription drug insurance on psychotropic and non-psychotropic drug utilization in Canada.
    Sarma S; Basu K; Gupta A
    Soc Sci Med; 2007 Dec; 65(12):2553-65. PubMed ID: 17761377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS).
    Darke S; Ross J; Teesson M; Ali R; Cooke R; Ritter A; Lynskey M
    J Subst Abuse Treat; 2005 Apr; 28(3):255-63. PubMed ID: 15857726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of baseline cocaine use on treatment outcomes for heroin dependence over 24 months: findings from the Australian Treatment Outcome Study.
    Williamson A; Darke S; Ross J; Teesson M
    J Subst Abuse Treat; 2007 Oct; 33(3):287-93. PubMed ID: 17889301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of nonfatal heroin overdose over a 3-year period: findings from the Australian treatment outcome study.
    Darke S; Williamson A; Ross J; Mills KL; Havard A; Teesson M
    J Urban Health; 2007 Mar; 84(2):283-91. PubMed ID: 17265131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-fatal heroin overdose, treatment exposure and client characteristics: findings from the Australian treatment outcome study (ATOS).
    Darke S; Williamson A; Ross J; Teesson M
    Drug Alcohol Rev; 2005 Sep; 24(5):425-32. PubMed ID: 16298837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical factors influencing the prescription of antidepressants and benzodiazepines: results from the European study of the epidemiology of mental disorders (ESEMeD).
    Demyttenaere K; Bonnewyn A; Bruffaerts R; De Girolamo G; Gasquet I; Kovess V; Haro JM; Alonso J
    J Affect Disord; 2008 Sep; 110(1-2):84-93. PubMed ID: 18329721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of post-traumatic stress disorder on treatment outcomes for heroin dependence.
    Mills KL; Teesson M; Ross J; Darke S
    Addiction; 2007 Mar; 102(3):447-54. PubMed ID: 17298653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.